News
![Why Molina Healthcare, China Lodging Group, and U.S. Silica Holdings Jumped Today](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Why Molina Healthcare, China Lodging Group, and U.S. Silica Holdings Jumped Today
The stock market fell sharply on Thursday, with major benchmarks finishing the day down between 1% and 2%. A terrorist attack in Barcelona reminded investors of the numerous geopolitical threats
![One Company That's Set to Win From Precision Medicine](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
One Company That's Set to Win From Precision Medicine
In the last few decades, incredible strides have been made in genome typing and precision medicine technology. What used to cost hundreds of thousands of dollars is now available for $100, opening up
![The Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
The Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think
The marijuana market may be on its way to being worth $25 billion in 2021, and advances in DNA research could lead to next-generation precision medicine worth billions of dollars in annual sales. Yet
![Why Community Health Systems, TripAdvisor, and Hostess Brands Jumped Today](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Why Community Health Systems, TripAdvisor, and Hostess Brands Jumped Today
The stock market finished a tumultuous week on a quiet note, as major benchmarks generally closed modestly higher while still finishing with substantial losses for the week as a whole. Investors
![Here's Why Synergy Pharmaceuticals Inc. Is Falling Today](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Here's Why Synergy Pharmaceuticals Inc. Is Falling Today
After posting a much higher loss than Wall Street expected, shares of Synergy Pharmaceuticals (NASDAQ: SGYP), a commercial-stage biopharma focused on diseases of the gastrointestinal system, fell as
![Here's Why Surgery Partners Inc. Is Sinking Today](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Here's Why Surgery Partners Inc. Is Sinking Today
Shares of Surgery Partners Inc. (NASDAQ: SGRY), a provider of surgical care services, tanked 52% shortly after the opening bell this morning in response to an earnings miss on the top and bottom
![Becton Dickinson and Co Faces a Rough Comparator](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Becton Dickinson and Co Faces a Rough Comparator
Becton, Dickinson (NYSE: BDX) reported a small drop in revenue and a substantial loss in its third fiscal quarter, but both issues are easily explainable as long as you don't mind ignoring GAAP, which
![Illumina Introduces a New Genomic Era](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Illumina Introduces a New Genomic Era
Illumina's (NASDAQ: ILMN) second-quarter earnings crushed expectations last week. Investors cheered the company's raised guidance, and the stock is up more than 15% since the report.Illumina's genomic
![Why Amedisys Shares Slumped 24.6% in July](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Why Amedisys Shares Slumped 24.6% in July
Amedisys Inc. (NASDAQ: AMED) shares lost nearly 25% of their value last month, according to S&P Global Market Intelligence. The drop was caused by word that the the federal government's Centers for
![Why Tenet Healthcare Shares Dropped 14.4% Today](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Why Tenet Healthcare Shares Dropped 14.4% Today
After reporting second-quarter earnings and offering up guidance for 2017, shares of Tenet Healthcare (NYSE: THC) have fallen 14.6% as of 2:30 p.m. EDT on Tuesday.Tenet Healthcare's year-over-year
![Why Avis Budget Group, Depomed, and Tenet Healthcare Slumped Today](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Why Avis Budget Group, Depomed, and Tenet Healthcare Slumped Today
Investors saw the end of a historic bullish streak for stocks on Tuesday, as the Dow Jones Industrials failed in their bid for a 10th straight day of record-setting gains. Instead, major benchmarks
![Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why?](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why?
Synergy Pharmaceuticals (NASDAQ: SGYP), a commercial-stage biopharma focused on gastrointestinal diseases, fell more than 14% in July, according to data from S&P Global Market Intelligence. However
![Why Evolent Health, Inc. Is Plunging Today](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Why Evolent Health, Inc. Is Plunging Today
In response to reporting second-quarter earnings and announcing a common stock offering, shares of Evolent Health (NYSE: EVH), a fast-growing digital health technology company that offers a
![Why Align Technology's Shares Soared 11.4% In July](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Why Align Technology's Shares Soared 11.4% In July
After Align Technology (NASDAQ: ALGN) reported case shipments had notched another quarterly increase, the company's shares climbed 11.4% in July, according to S&P Global Market Intelligence. Growing
![What's Behind Pacific Biosciences of California's Stock Rally Today?](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
What's Behind Pacific Biosciences of California's Stock Rally Today?
Shares of Pacific Biosciences of California (NASDAQ: PACB) are on the rise again. This is the third trading session in a row that the stock has marched upwards since announcing record revenues and a
![Is Illumina Stock a Buy at Nearly 40 Times Earnings? 1 Analyst Thinks So](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Is Illumina Stock a Buy at Nearly 40 Times Earnings? 1 Analyst Thinks So
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one
![Here's Why Mazor Robotics Ltd. Gained 20% in July](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Here's Why Mazor Robotics Ltd. Gained 20% in July
Shares of robot-assisted surgery start-up Mazor Robotics Ltd. (NASDAQ: MZOR) gained 20% in July, according to data from S&P Global Market Intelligence. The market boosted the stock in response to news
![Insulet Delivers 26% Revenue Growth and Raises 2017 Guidance; Stock Pumps Up 7%](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Insulet Delivers 26% Revenue Growth and Raises 2017 Guidance; Stock Pumps Up 7%
Insulet (NASDAQ: PODD) reported second-quarter 2017 earnings after the market closed on Thursday. The drug-delivery company, which is a leader in tubeless insulin pump technology with its Omnipod
![Down 9.8%: Is Masimo Corporation Stock a Contrarian Buy?](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Down 9.8%: Is Masimo Corporation Stock a Contrarian Buy?
Masimo Corporation (NASDAQ: MASI), a mid-cap medical technology company, reported stronger-than-expected second-quarter results after the bell Wednesday, but investors still decided to hit the exits
![Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?
Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG) recently reported second-quarter earnings that were better than industry watchers' forecasts. These two game-changing healthcare companies
![Here's Why Pacific Biosciences of California Is Surging Today](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Here's Why Pacific Biosciences of California Is Surging Today
Shares of Pacific Biosciences of California (NASDAQ: PACB), a purveyor of high-accuracy genomic sequencing kits, is marching higher after reporting second-quarter earnings and a big order from a
![Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone
In response to reporting rough second-quarter results, shares of Teva Pharmaceutical Industries (NYSE: TEVA), a leading provider of generic drugs, dropped 24% as of 1:15 p.m. EDT on Thursday.Here's a
![Why OraSure Technologies, Inc. Jumped Higher Today](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Why OraSure Technologies, Inc. Jumped Higher Today
OraSure Technologies (NASDAQ: OSUR) is up 16.5% at 12:08 p.m. EDT after reporting stellar second-quarter earnings Wednesday afternoon.Revenue was up 28% year over year. More impressively, there was a
![Why Wright Medical Group Shares Are Spiking Higher Today](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Why Wright Medical Group Shares Are Spiking Higher Today
Shares of Wright Medical Group (NASDAQ: WMGI) were trading 10% higher earlier today after management reported second-quarter financial results that outpaced industry watchers' forecasts.Wright Medical
![Here's What's Pressuring Glaukos Corp Stock Today](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Here's What's Pressuring Glaukos Corp Stock Today
Shares of Glaukos Corp (NYSE: GKOS), a medical technology company focused on glaucoma treatment, were down about 9.8% as of 11:46 a.m. on Thursday in response to a second-quarter earnings report